“I used to fall down a lot.” When Kwong was 57 she was diagnosed with osteoporosis, a disease caused by a decrease in bone density that renders them fragile. It was this that caused her fall ...
The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with advanced Parkinson’s disease. This novel treatment is the first of its ...
Professor Rupesh K Srivastava shared the information during a presentation at the 51st IMMUNOCON 2024, a four-day annual conference of the Indian Immunology Society held at the JN Tata Auditorium ...
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...
Vyalev combines foscarbidopa, a prodrug of carbidopa, and foslevodopa, a prodrug of levodopa, into a solution for continuous subcutaneous 24-hour infusion. The Food and Drug Administration (FDA ...
"For too long, the Parkinson's community has had limited treatment options for advanced disease," Dr. Robert A. Hauser, professor of neurology at the University of South Florida said in a press ...
These diseases range from mild gingivitis, which causes red, swollen, and bleeding gums, to more severe forms like periodontitis, which can lead to tooth loss if untreated. Periodontal diseases ...